Product Code: TIPRE00003017
The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021-2028.
The report highlights the key factors driving the market and prominent players with their developments. The growth of the liver cancer diagnostics market is primarily attributed to the rising prevalence of liver cancer and increasing R&D investments in the development of novel diagnostic testing. On the other hand, the high cost of technologically advanced liver cancer diagnostic solutions hinders the growth of the market.
Hepatocellular carcinoma is the most frequent type of liver; it starts in the major type of liver cell (hepatocyte) and is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Further, other kinds of liver cancer are significantly less prevalent, such as intrahepatic cholangiocarcinoma and hepatoblastoma. Cancer that begins in another area of the body, such as the colon, lung, or breast, and then spreads to the liver is called metastatic cancer. Moreover, metastatic colon cancer is a kind of cancer that starts in the colon and spreads to the liver. For instance, according to CDC (Centers of Disease Control and Prevention), each year in the US, about 24,500 men and 10,000 women get liver cancer, and about 18,600 men and 9,000 women die from the disease. The percentage of Americans who get liver cancer has been rising for several decades. Liver cancer is more common in other parts of the world than in the US. Moreover, according to an article published in CCO (Chinese Clinical Oncology), hepatocellular cancer (HCC) is a leading cause of cancer death worldwide. In Europe, HCC accounts for around 47,000 deaths per year. The incidence is comparatively low except in Southern Europe, where the age-standardized incidence rate in men is 9.8 per 100,000 compared with 3.8 in Northern Europe, 4.6 in central and Eastern Europe, and 7.2 in Western Europe. However, in the UK, mortality rates from HCC are expected to rise by 14% between 2006 and 2025 representing the largest increase in any male cancer. Furthermore, being overweight or having obesity is a risk factor for liver cancer and non-alcoholic fatty liver disease is a common condition in obese people. People with a subtype of non-alcoholic fatty liver disease, known as non-alcoholic steatohepatitis (NASH), might develop cirrhosis, which can cause liver cancer. According to a research article by Eunsun Kim et al., published in Experimental & Molecular Medicine Journal 2020, the incidence rate associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing, and the global burden of mortality from hepatocellular carcinoma (HCC) is predicted to reach 1 million deaths annually by 2030. In addition, certain inherited metabolic diseases can lead to cirrhosis. Lifestyle and behaviors such as smoking cigarettes and drinking alcohol are the leading cause of cirrhosis in the US, which is linked with an increased risk of liver cancer. Further, Type 2 diabetes has been linked with an increased risk of liver cancer, usually in patients with other risk factors such as heavy alcohol use or chronic viral hepatitis. This risk may also be increased as people with type 2 diabetes tend to be overweight or obese, which, in turn, can cause liver problems. According to IDF Diabetes Atlas Tenth edition 2021, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The factors mentioned above are increasing the chances of liver cancer, thereby driving the liver cancer diagnostics market.
The global liver cancer diagnostics market, based on type, is segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The market for the laboratory tests segment is further segmented into blood tests and biomarkers. The laboratory tests segment held the largest share of the market in 2021. However, the imaging segment is anticipated to register a CAGR of 8.5% in the market during the forecast period. Based on end user, the global liver cancer diagnostics market is segmented into hospitals and diagnostic laboratories, academic and research institutes, and CRO laboratories. The hospitals and diagnostic laboratories segment held the largest share of the market in 2021 as the hospitals provide healthcare facilities through specialized scientific equipment. A team of trained staff is assigned to deal, investigate, and restore the problems associated with modern medical science in the hospital. Various medical research teams are constantly working on introducing innovative technologies related to the diagnostics methods and other activities in the medical field. The patients generally prefer the hospital to take liver cancer treatment due to the availability of advanced treatment options. The hospitals are the point of care for the patients. Moreover, the same segment is anticipated to register a CAGR of 8.5% in the market during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the liver cancer diagnostics market are the National Center for Health Statistics; Centers for Disease Control and Prevention (CDC); National Institute of Statistics, Geography, and Informatics; National Health and Medical Research Council; and World Health Organization.
Reasons to Buy:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global liver cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global liver cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Liver Cancer Diagnostics Market - By Type
- 1.3.2 Global Liver Cancer Diagnostics Market - By End User
- 1.3.3 Global Liver Cancer Diagnostics Market - By Geography
2. Liver Cancer Diagnostics Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Liver Cancer Diagnostics Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South And Central America PEST Analysis
- 4.3 Experts Opinion
5. Liver Cancer Diagnostics Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Prevalence of Liver Cancer
- 5.1.2 Rising R&D Investments for the Development of Novel Diagnostic Testing
- 5.2 Market Restraints
- 5.2.1 High Cost of Technologically Advanced Liver Cancer Diagnostic Solutions
- 5.3 Market Opportunities
- 5.3.1 Increasing Demand for Point-of-Care Testing
- 5.4 Future Trends
- 5.4.1 Rising Emergence of New Technologies
- 5.5 Impact Analysis
6. Liver Cancer Diagnostics Market - Global Analysis
- 6.1 Global Liver Cancer Diagnostics Market Revenue Forecast and Analysis
- 6.2 Global Liver Cancer Diagnostics Market, By Geography - Forecast and Analysis
- 6.3 Market Positioning of Key Players
7. Liver Cancer Diagnostics Market Analysis - By Type
- 7.1 Overview
- 7.2 Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
- 7.3 Laboratory Tests
- 7.3.1 Overview
- 7.3.2 Laboratory Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.1 Blood Tests
- 7.3.2.1.1 Overview
- 7.3.2.1.2 Blood Tests: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.2 Biomarkers
- 7.3.2.2.1 Overview
- 7.3.2.2.2 Biomarkers: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Endoscopy
- 7.4.1 Overview
- 7.4.2 Endoscopy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Imaging
- 7.5.1 Overview
- 7.5.2 Imaging: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Biopsy
- 7.6.1 Overview
- 7.6.2 Biopsy: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Liver Cancer Diagnostics Market Analysis - By End User
- 8.1 Overview
- 8.2 Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)
- 8.3 Hospitals and Diagnostics Laboratories
- 8.3.1 Overview
- 8.3.2 Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Academic and Research Institutes
- 8.4.1 Overview
- 8.4.2 Academic and Research Institutes: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 CRO Laboratories
- 8.5.1 Overview
- 8.5.2 CRO Laboratories: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
9. Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 - Geographical Analysis
- 9.1 North America: Liver Cancer Diagnostics Market
- 9.1.1 Overview
- 9.1.2 North America Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.3 North America Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
- 9.1.3.1 North America Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.1.4 North America Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
- 9.1.5 North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
- 9.1.5.1 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.1 Overview
- 9.1.5.1.2 US: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.3 US Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.3.1 US Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.1.4 US Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.1 Overview
- 9.1.5.2.2 Canada: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.3 Canada Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.3.1 Canada Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.2.4 Canada Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.1 Overview
- 9.1.5.3.2 Mexico: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.3 Mexico Liver Cancer Diagnostics Market, by Type- Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.3.1 Mexico Liver Cancer Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.1.5.3.4 Mexico Liver Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
- 9.2 Europe: Liver Cancer Diagnostics Market
- 9.2.1 Overview
- 9.2.2 Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.3 Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.3.1 Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.4 Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5 Europe: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
- 9.2.5.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.1.1 Germany: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.1.2 Germany: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.1.2.1 Germany: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.1.3 Germany: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5.2 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.2.1 UK: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.2.2 UK: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.2.2.1 UK: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.2.3 UK: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5.3 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.3.1 France: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.3.2 France: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.3.2.1 France: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.3.3 France: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5.4 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.4.1 Spain: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.4.2 Spain: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.4.2.1 Spain: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.4.3 Spain: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5.5 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.5.1 Italy: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.5.2 Italy: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.5.2.1 Italy: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.5.3 Italy: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.2.5.6 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.6.1 Rest of Europe: Liver Cancer Diagnostics Market - Revenue and forecast to 2028 (USD Million)
- 9.2.5.6.2 Rest of Europe: Liver Cancer Diagnostics Market, by Type, 2019-2028 (USD Million)
- 9.2.5.6.2.1 Rest of Europe: Liver Cancer Diagnostics Market, by Laboratory Tests, 2019-2028 (USD Million)
- 9.2.5.6.3 Rest of Europe: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.3 Asia-Pacific: Liver Cancer Diagnostics Market
- 9.3.1 Overview
- 9.3.2 Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.3 Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.3.1 Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
- 9.3.4 Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5 Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
- 9.3.5.1 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.1.1 Overview
- 9.3.5.1.2 China: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.1.3 China: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.1.3.1 China: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
- 9.3.5.1.4 China: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.2.1 Overview
- 9.3.5.2.2 Japan: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.2.3 Japan: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.2.3.1 Japan: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
- 9.3.5.2.4 Japan: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5.3 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.3.1 Overview
- 9.3.5.3.2 India: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.3.3 India: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.3.3.1 India: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
- 9.3.5.3.4 India: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5.4 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.4.1 Overview
- 9.3.5.4.2 South Korea: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.4.3 South Korea: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.4.3.1 South Korea: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
- 9.3.5.4.4 South Korea: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5.5 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.5.1 Overview
- 9.3.5.5.2 Australia: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.5.3 Australia: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.5.3.1 Australia: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019-2028 (USD Million)
- 9.3.5.5.4 Australia: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.3.5.6 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.6.1 Overview
- 9.3.5.6.2 Rest of Asia-Pacific: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3.5.6.3 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Type- 2019-2028 (USD Million)
- 9.3.5.6.3.1 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019-2028 (USD Million)
- 9.3.5.6.4 Rest of Asia-Pacific: Liver Cancer Diagnostics Market, by End User- 2019-2028 (USD Million)
- 9.4 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
- 9.4.1 Overview
- 9.4.2 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.3 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 9.4.3.1 Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
- 9.4.4 Middle East & Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5 Middle East & Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
- 9.4.5.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.1.1 Overview
- 9.4.5.1.2 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.1.3 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 9.4.5.1.3.1 UAE: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
- 9.4.5.1.4 UAE: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.2.1 Overview
- 9.4.5.2.2 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.2.3 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 9.4.5.2.3.1 Saudi Arabia: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
- 9.4.5.2.4 Saudi Arabia: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.3.1 Overview
- 9.4.5.3.2 South Africa Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.3.3 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 9.4.5.3.3.1 South Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
- 9.4.5.3.4 South Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
- 9.4.5.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.4.1 Overview
- 9.4.5.4.2 Rest of Middle East and Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
- 9.4.5.4.3 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Type (US$ Million)
- 9.4.5.4.3.1 Rest of Middle East & Africa: Liver Cancer Diagnostics Market Revenue and Forecasts to 2028, By Laboratory Tests (US$ Million)
- 9.4.5.4.4 Rest of Middle East and Africa: Liver Cancer Diagnostics Market, by End user - Revenue and Forecast to 2028 (US$ Million)
- 9.5 South and Central America Liver Cancer Diagnostics Market Revenue and Forecasts To 2028
- 9.5.1 Overview
- 9.5.2 South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.5.3 South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
- 9.5.3.1 South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.5.4 South and Central America: Liver Cancer Diagnostics Market, by End User, 2019-2028 (USD Million)
- 9.5.5 South and Central America: Liver Cancer Diagnostics Market Share by Country - 2021 & 2028, (%)
- 9.5.5.1 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
- 9.5.5.1.1 Overview
- 9.5.5.1.2 Brazil: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
- 9.5.5.1.3 Brazil Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
- 9.5.5.1.3.1 Brazil Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.1.4 Brazil Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
- 9.5.5.2.1 Overview
- 9.5.5.2.2 Argentina: Liver Cancer Diagnostics Market- Revenue and Forecasts To 2028 (USD Million)
- 9.5.5.2.3 Argentina Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
- 9.5.5.2.3.1 Argentina Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.2.4 Argentina Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3.1 Overview
- 9.5.5.3.2 Rest of South and Central America: Liver Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3.3 Rest of South and Central America Liver Cancer Diagnostics Market, By Type- Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3.3.1 Rest of South and Central America Liver Cancer Diagnostics Market, By Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
- 9.5.5.3.4 Rest of South and Central America Liver Cancer Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Liver Cancer Diagnostics Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 10.2 Europe: Impact Assessment of COVID-19 Pandemic
- 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
- 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Liver Cancer Diagnostics Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Liver Cancer Diagnostics Market (%)
- 11.3 Organic Developments
- 11.4 Inorganic Developments
12. Company Profiles
- 12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 bioMerieux SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 F. HOFFMANN-LA ROCHE LTD.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Illumina, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Koninklijke Philips N.V.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 QIAGEN
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Siemens Healthineers AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 THERMO FISHER SCIENTIFIC INC.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 GE Healthcare
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Perspectum
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Helio, Inc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms